Ho Maykin has filed 37 insider transactions across 4 companies since May 2023.
Most recent transaction: a grant/award of 15768 shares of AGIOS PHARMACEUTICALS, INC. ($AGIO) on June 18, 2025.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 18, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Ho Maykin | Director | A | Stock options (right to buy) | 15768 | $0.00 | 15,768.0000 | 74,103,192,000 | 9999.99% | 0.00% |
| June 20, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Ho Maykin | Director | M | Common stock | 2120 | $0.00 | 17,032.0000 | 74,103,192,000 | 14.22% | 0.00% |
| June 18, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Ho Maykin | Director | A | Restricted stock units | 2816 | $0.00 | 2,816.0000 | 74,103,192,000 | 9999.99% | 0.00% |
| June 20, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Ho Maykin | Director | M | Restricted stock units | 2120 | $0.00 | 0.0000 | 74,103,192,000 | 100.00% | 0.00% |
| June 4, 2025 | KYNTRA BIO, INC. | $KYNB | Ho Maykin | Not found | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 100,917,000 | 9999.99% | 0.12% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Ho Maykin | Not found | D | Stock Option (Right to Buy) | 95586 | $0.00 | 0.0000 | 161,978,923 | 100.00% | 0.06% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Ho Maykin | Not found | D | Stock Option (Right to Buy) | 27802 | $0.00 | 0.0000 | 161,978,923 | 100.00% | 0.02% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Ho Maykin | Not found | D | Stock Option (Right to Buy) | 28571 | $0.00 | 0.0000 | 161,978,923 | 100.00% | 0.02% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Ho Maykin | Not found | A | Stock Option (Right to Buy) | 95586 | $0.00 | 95,586.0000 | 161,978,923 | 9999.99% | 0.06% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Ho Maykin | Not found | A | Stock Option (Right to Buy) | 27802 | $0.00 | 27,802.0000 | 161,978,923 | 9999.99% | 0.02% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Ho Maykin | Not found | A | Stock Option (Right to Buy) | 28571 | $0.00 | 28,571.0000 | 161,978,923 | 9999.99% | 0.02% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Ho Maykin | Not found | A | Stock Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 161,978,923 | 9999.99% | 0.05% |
| May 20, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ho Maykin | Director | A | Common Stock | 6650 | $0.00 | 28,010.0000 | 196,708,000 | 31.13% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Ho Maykin | Not found | A | Stock Option (Right to Buy) | 95586 | $0.00 | 95,586.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Ho Maykin | Not found | D | Stock Option (Right to Buy) | 95586 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Ho Maykin | Not found | D | Stock Option (Right to Buy) | 27802 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Ho Maykin | Not found | D | Stock Option (Right to Buy) | 28571 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Ho Maykin | Not found | A | Stock Option (Right to Buy) | 27802 | $0.00 | 27,802.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Ho Maykin | Not found | A | Stock Option (Right to Buy) | 28571 | $0.00 | 28,571.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Ho Maykin | Director | A | Restricted stock units | 2120 | $0.00 | 2,120.0000 | 72,967,922,000 | 9999.99% | 0.00% |
| June 20, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Ho Maykin | Director | A | Stock options (right to buy) | 11774 | $0.00 | 11,774.0000 | 72,967,922,000 | 9999.99% | 0.00% |
| June 13, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Ho Maykin | Director | M | Common stock | 3388 | $0.00 | 14,912.0000 | 72,967,922,000 | 29.40% | 0.00% |
| June 13, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Ho Maykin | Director | M | Restricted stock units | 3388 | $0.00 | 0.0000 | 72,967,922,000 | 100.00% | 0.00% |
| June 13, 2024 | Neumora Therapeutics, Inc. | $NMRA | Ho Maykin | Not found | A | Stock Option (Right to Buy) | 28571 | $0.00 | 28,571.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Neumora Therapeutics, Inc. | $NMRA | Ho Maykin | Not found | A | Common Stock | 20100 | $0.00 | 20,100.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | KYNTRA BIO, INC. | $KYNB | Ho Maykin | Not found | A | Stock Option (Right to Buy) | 70000 | $0.00 | 70,000.0000 | 98,770,000 | 9999.99% | 0.07% |
| May 21, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ho Maykin | Director | A | Common Stock | 4720 | $0.00 | 21,360.0000 | 191,595,000 | 28.37% | 0.00% |
| Sept. 14, 2023 | Neumora Therapeutics, Inc. | $NMRA | Ho Maykin | Not found | A | Stock Option (Right to Buy) | 27802 | $0.00 | 27,802.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Ho Maykin | Director | M | Common stock | 4975 | $0.00 | 11,524.0000 | 71,256,118 | 75.97% | 0.01% |
| June 21, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Ho Maykin | Director | M | Restricted stock unit | 4975 | $0.00 | 0.0000 | 71,256,118 | 100.00% | 0.01% |
| June 13, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Ho Maykin | Director | A | Restricted stock units | 3388 | $0.00 | 3,388.0000 | 71,256,118 | 9999.99% | 0.00% |
| June 13, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Ho Maykin | Director | A | Stock options (right to buy) | 18958 | $0.00 | 18,958.0000 | 71,256,118 | 9999.99% | 0.03% |
| June 7, 2023 | KYNTRA BIO, INC. | $KYNB | Ho Maykin | Director | A | Common Stock | 8289 | $0.00 | 40,021.0000 | 0 | 26.12% | 0.00% |
| June 8, 2023 | KYNTRA BIO, INC. | $KYNB | Ho Maykin | Director | S | Common Stock | 6225 | $17.68 | 31,501.0000 | 0 | 16.50% | 0.00% |
| June 7, 2023 | KYNTRA BIO, INC. | $KYNB | Ho Maykin | Director | A | Stock Option (Right to Buy) | 12666 | $0.00 | 12,666.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | KYNTRA BIO, INC. | $KYNB | Ho Maykin | Director | S | Common Stock | 2295 | $16.79 | 37,726.0000 | 0 | 5.73% | 0.00% |
| May 23, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Ho Maykin | Director | A | Common Stock | 4190 | $0.00 | 16,640.0000 | 188,963,000 | 33.65% | 0.00% |